These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6440476)
1. Comparative in vitro activities of apalcillin and piperacillin against gram-negative bacilli. Fass RJ; Helsel VL Antimicrob Agents Chemother; 1984 Nov; 26(5):660-4. PubMed ID: 6440476 [TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activities of cefpiramide and apalcillin individually and in combination. Allan JD; Eliopoulos GM; Ferraro MJ; Moellering RC Antimicrob Agents Chemother; 1985 May; 27(5):782-90. PubMed ID: 3925875 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centers. Barry AL; Jones RN; Ayers LW; Gavan TL; Gerlach EH; Sommers HM Antimicrob Agents Chemother; 1984 May; 25(5):669-71. PubMed ID: 6732234 [TBL] [Abstract][Full Text] [Related]
4. Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests. Barry AL; Thornsberry C; Jones RN; Gavan TL J Clin Microbiol; 1984 Jun; 19(6):777-82. PubMed ID: 6432833 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of cefpiramide (SM-1652) against gram-negative bacilli. Fass RJ; Helsel VL Diagn Microbiol Infect Dis; 1986 Jan; 4(1):77-81. PubMed ID: 3943292 [TBL] [Abstract][Full Text] [Related]
6. [Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study]. Quentin C; Auzerie J; Bebear C; Acar JF; Kitzis MD; Avril JL; Moillo-Batt A; Shacoori Z; Bergogne-Berezin E; Joly-Guillou ML Pathol Biol (Paris); 1984 May; 32(5):301-6. PubMed ID: 6429608 [TBL] [Abstract][Full Text] [Related]
7. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter]. Quentin C; Sageaux JC; Bebear C; Latrille J Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123 [TBL] [Abstract][Full Text] [Related]
8. Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition. Barry AL; Jones RN; Thornsberry C Diagn Microbiol Infect Dis; 1985 Jan; 3(1):7-17. PubMed ID: 3871382 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins. Neu HC; Labthavikul P Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375 [TBL] [Abstract][Full Text] [Related]
10. Activity of apalcillin against Pseudomonas aeruginosa. Hollick GE; Gundrum J; Venezia RA Antimicrob Agents Chemother; 1984 Sep; 26(3):408-9. PubMed ID: 6439115 [TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates. Noguchi H; Kubo M; Kurashige S; Mitsuhashi S Antimicrob Agents Chemother; 1978 May; 13(5):745-52. PubMed ID: 248269 [TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria. Wexler H; Carter WT; Harris B; Finegold SM Antimicrob Agents Chemother; 1984 Feb; 25(2):162-4. PubMed ID: 6712200 [TBL] [Abstract][Full Text] [Related]
13. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830). Jones RN; Barry AL Diagn Microbiol Infect Dis; 1989; 12(6):495-510. PubMed ID: 2560422 [TBL] [Abstract][Full Text] [Related]
14. [Antibacterial activity of apalcillin against 300 strains of enterobacteria]. Coulet M; Forey F; Brun Y; Fleurette J Pathol Biol (Paris); 1983 May; 31(5):311-8. PubMed ID: 6353323 [TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam. Sader HS; Tosin I; Sejas L; Miranda E Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842 [TBL] [Abstract][Full Text] [Related]
16. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads. Jacobs MR; Aronoff SC; Johenning S; Yamabe S J Antimicrob Chemother; 1986 Aug; 18(2):177-84. PubMed ID: 3019984 [TBL] [Abstract][Full Text] [Related]
17. [In vitro antibacterial activity of apalcillin on aerobic bacteria and the regression curve]. Soussy CJ; Duval J; Chanal M; Sirot D; Bergogne-Bérézin E; Joly-Guillou ML; Malbruny B; Morel C Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):660-4. PubMed ID: 3054743 [TBL] [Abstract][Full Text] [Related]
18. [Comparative effect of apalcillin and other beta-lactam antibiotics against the Bacteroides fragilis group]. Dusart G; Simeon de Buochberg M; Zuccarelli M; Attisso MA; Willemin C Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):523-7. PubMed ID: 2797878 [TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of enoxacin against aminoglycoside-resistant gram-negative bacilli and other clinical isolates. Duncan IB; Skulnick M; Marshall PW J Antimicrob Chemother; 1984 Sep; 14 Suppl C():1-6. PubMed ID: 6438046 [TBL] [Abstract][Full Text] [Related]
20. Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests. Barry AL; Thornsberry C; Jones RN; Gavan TL Rev Infect Dis; 1985; 7 Suppl 4():S594-604. PubMed ID: 3909316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]